Target expression details
| Target's General Information | |||||
|---|---|---|---|---|---|
| Target ID | T86264 | ||||
| Target Name | Solute carrier family 40 member 1 (SLC40A1) | ||||
| Synonyms | SLC11A3; MSTP079; IREG1; Ferroportin-1; FPN1 | ||||
| Target Type | Clinical trial | ||||
| Gene Name | SLC40A1 | ||||
| Biochemical Class | Ferroportin protein | ||||
| UniProt ID | S40A1_HUMAN | ||||
| Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
| Disease | Anemia | ||||
| Example drug | LY2928057 | Phase 1 | [1], [2] | ||
| Tissue | Bone marrow | ||||
| Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: 0.15 Z-score: 0.5 P-value: 6.38E-02 |
||||
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01330953) A First Human Study of a Ferroportin Antibody. U.S. National Institutes of Health. | ||||
| REF 2 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.